The high expression of PSAT1 in tumor tissues, especially late-stage tumor tissues, combined with clinical data, in this nomogram enhances its prognostic value in different-stage ccRCC patients, particularly for the prediction of OS. This evidence concerns the gene PSAT1 and nonpapillary renal cell carcinoma.